Indian Immunologiclas to start drug substance production for Covaxin from June

Managing Director K Anand Kumar in a release on Friday said the firm is expected to produce the drug substance initially for 2-3 million doses per month.

from News-Economic Times https://ift.tt/3yMo1jK